ALLMedicine™ Mechanical Back Pain Center

May 17th, 2020 - Presence of human leucocyte antigen (HLA) B27 in a patient with lower-back pain should not be considered synonymous with axial spondyloarthritis. Other causes of back pain should be ruled-out by careful evaluation. Lumbosacral transitional vertebr...

Jan 19th, 2020 - We sought to evaluate the feasibility for awake, endoscopic treatment of lumbar pseudarthrosis after a transforaminal lumbar interbody fusion (TLIF). A 71-year-old male with severe cardiac disease, determined to be high risk for general anesthesia...

Jan 24th, 2019 - A 68-year-old man on apixaban presented to the emergency department with back pain following a long-haul flight. Investigations for pulmonary embolus and aortic dissection were negative and he was discharged with analgesia for mechanical back pain...

Oct 11th, 2018 - The aim of this study is to evaluate the diagnostic utility of ultrasonographic enthesitis assessment in patients with non-radiographic axial spondyloarthritis (nr-axSpA) and to compare different sonographic scoring methods. Patients with nr-axSpA...

Jul 21st, 2018 - There is a relative lack of confidence among GPs in the assessment and management of IBP vs. mechanical back pain. A simple screening tool for SpA, applicable in primary care urgently needs to be developed. It is reasonable for patients with sympt...

Lower back pain (LBP) is one of the most common health problems worldwide1–3 and is the leading cause of work absenteeism.4 LBP accounts for 3%–4% of all emergency department (ED) presentations,5 and current ED analgesic options include acetam...

May 17th, 2020 - Presence of human leucocyte antigen (HLA) B27 in a patient with lower-back pain should not be considered synonymous with axial spondyloarthritis. Other causes of back pain should be ruled-out by careful evaluation. Lumbosacral transitional vertebr...

Jan 19th, 2020 - We sought to evaluate the feasibility for awake, endoscopic treatment of lumbar pseudarthrosis after a transforaminal lumbar interbody fusion (TLIF). A 71-year-old male with severe cardiac disease, determined to be high risk for general anesthesia...

Jan 24th, 2019 - A 68-year-old man on apixaban presented to the emergency department with back pain following a long-haul flight. Investigations for pulmonary embolus and aortic dissection were negative and he was discharged with analgesia for mechanical back pain...

Oct 11th, 2018 - The aim of this study is to evaluate the diagnostic utility of ultrasonographic enthesitis assessment in patients with non-radiographic axial spondyloarthritis (nr-axSpA) and to compare different sonographic scoring methods. Patients with nr-axSpA...

Jul 21st, 2018 - There is a relative lack of confidence among GPs in the assessment and management of IBP vs. mechanical back pain. A simple screening tool for SpA, applicable in primary care urgently needs to be developed. It is reasonable for patients with sympt...

Aug 23rd, 2017 - The manifestation of multiple features of spondyloarthritis (SpA) in patients with chronic back pain is not sufficient for a diagnosis of axial spondyloarthritis, according to a report from Zineb Ez-Zaitouni and associates. In a group of 250 peopl.

Apr 28th, 2017 - Action Points Note that this observational study found that MRI findings traditionally associated with "wear and tear" damage were associated with inflammatory back pain symptoms. Be aware that inflammatory symptoms were assessed via questionnaire...

Jul 12th, 2013 - MADRID – There is no added benefit of performing spinal MRI in the diagnosis of spondyloarthritis, the results of an international, multicenter study suggest. Around one-quarter of patients with nonradiographic axial spondyloarthritis (nr-axSpA) w.

May 12th, 2011 - CHICAGO – Despite dramatic clinical benefit, the standard treatments for ankylosing spondylitis do not appear to alter the natural history of the disease. "We’d like to believe we’re actually doing something substantial for our patients in additio.

May 1st, 2011 - CHICAGO – Despite dramatic clinical benefit, the standard treatments for ankylosing spondylitis do not appear to alter the natural history of the disease. “We'd like to believe we're actually doing something substantial for our patients in additio.